Molecular signatures differentiate immune states in Type 1 diabetes families
- Yi-Guang Chen1,
- Susanne M. Cabrera1,
- Shuang Jia1,
- Mary L. Kaldunski1,
- Joanna Kramer1,
- Sami Cheong2,
- Rhonda Geoffrey1,
- Mark F. Roethle1,
- Jeffrey E. Woodliff3,
- Carla J. Greenbaum4,
- Xujing Wang5 and
- Martin J. Hessner1⇑
- 1The Max McGee National Research Center for Juvenile Diabetes, Children's Research Institute of Children's Hospital of Wisconsin, and Department of Pediatrics at the Medical College of Wisconsin Milwaukee, WI 53226, USA.
- 2The Department of Mathematical Sciences, University of Wisconsin-Milwaukee, Milwaukee, WI 53211, USA.
- 3Flow Cytometry & Cell Separation Facility, Bindley Bioscience Center, Purdue University, West Lafayette, IN 47907, USA.
- 4Diabetes Research Program, Benaroya Research Institute, Seattle, WA, 98101, USA.
- 5Systems Biology Center, the National Heart, Lung, and Blood Institute, the National Institutes of Health, Bethesda, MD 20824, USA.
- Corresponding author: Martin J. Hessner, E-mail: .
Mechanisms associated with Type 1 diabetes (T1D) development remain incompletely defined. Employing a sensitive array-based bioassay where patient plasma is used to induce transcriptional responses in healthy leukocytes, we previously reported disease-specific, partially IL-1 dependent, signatures associated with pre and recent onset (RO) T1D relative to unrelated healthy controls (uHC). To better understand inherited susceptibility in T1D families, we conducted cross-sectional and longitudinal analyses of healthy auto-antibody-negative (AA-) high HLA risk siblings (HRS, DR3 and/or DR4) and AA- low HLA risk siblings (LRS, non-DR3/non-DR4). Signatures, scored with a novel ontology-based algorithm, and confirmatory studies differentiated the RO T1D, uHC, HRS, and LRS plasma milieus. Relative to uHC, T1D family members exhibited an elevated inflammatory state, consistent with innate receptor ligation that was independent of HLA, AA, or disease status and included elevated plasma IL-1α, IL-12p40, CCL2, CCL3, and CCL4 levels. Longitudinally, signatures of T1D progressors exhibited increasing inflammatory bias. Conversely HRS possessing decreasing AA titers revealed emergence of an IL-10/TGF-β mediated regulatory state that paralleled temporal increases in peripheral activated CD4+/CD45RA-/FoxP3high regulatory T-cell frequencies. In AA- HRS, the familial innate inflammatory state was also temporally supplanted by immunoregulatory processes, suggesting a mechanism underlying the decline in T1D susceptibility with age.
- Received February 6, 2014.
- Accepted April 21, 2014.
- © 2014 by the American Diabetes Association.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.